JP2024544404A - Ｓｈｒ０３０２の安定な製剤 - Google Patents
Ｓｈｒ０３０２の安定な製剤 Download PDFInfo
- Publication number
- JP2024544404A JP2024544404A JP2024536283A JP2024536283A JP2024544404A JP 2024544404 A JP2024544404 A JP 2024544404A JP 2024536283 A JP2024536283 A JP 2024536283A JP 2024536283 A JP2024536283 A JP 2024536283A JP 2024544404 A JP2024544404 A JP 2024544404A
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- topical pharmaceutical
- amount
- shr0302
- months
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289780P | 2021-12-15 | 2021-12-15 | |
| US63/289,780 | 2021-12-15 | ||
| US202263370740P | 2022-08-08 | 2022-08-08 | |
| US63/370,740 | 2022-08-08 | ||
| PCT/US2022/081535 WO2023114832A1 (en) | 2021-12-15 | 2022-12-14 | Stable formulations of shr0302 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544404A true JP2024544404A (ja) | 2024-11-29 |
| JP2024544404A5 JP2024544404A5 (https=) | 2025-12-23 |
Family
ID=85018901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536283A Pending JP2024544404A (ja) | 2021-12-15 | 2022-12-14 | Ｓｈｒ０３０２の安定な製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12161643B2 (https=) |
| EP (1) | EP4447930A1 (https=) |
| JP (1) | JP2024544404A (https=) |
| KR (1) | KR20240125610A (https=) |
| AU (1) | AU2022413551A1 (https=) |
| CA (1) | CA3240662A1 (https=) |
| IL (1) | IL313482A (https=) |
| MX (1) | MX2024007437A (https=) |
| WO (1) | WO2023114832A1 (https=) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3711602A (en) * | 1970-10-30 | 1973-01-16 | Crown Zellerbach Corp | Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso |
| US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
| JP5732471B2 (ja) | 2009-12-22 | 2015-06-10 | レオ ファーマ アクティーゼルスカブ | 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体 |
| PT2796460T (pt) * | 2011-12-21 | 2018-11-05 | Shanghai hengrui pharmaceutical co ltd | Derivado pirrole de anel heteroarilo de seis membros, método de preparação do mesmo e suas utilizações médicas |
| PT3006445T (pt) | 2013-06-07 | 2018-01-09 | Jiangsu Hengrui Medicine Co | Bissulfato de inibidor de janus quinase (jak) e método de preparação para o mesmo |
| CN105566327A (zh) | 2014-10-09 | 2016-05-11 | 江苏恒瑞医药股份有限公司 | 一种jak激酶抑制剂的硫酸氢盐的i型结晶及其制备方法 |
| WO2016070697A1 (zh) | 2014-11-05 | 2016-05-12 | 江苏恒瑞医药股份有限公司 | 一种jak激酶抑制剂的硫酸氢盐的结晶形式及其制备方法 |
| CA3014090A1 (en) | 2016-02-19 | 2017-08-24 | Jiangsu Hengrui Medicine Co., Ltd. | Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof |
| US20190060311A1 (en) | 2017-08-24 | 2019-02-28 | Aclaris Therapeutics, Inc. | Compositions and methods for treatment of vitiligo |
| SG11202001706RA (en) | 2017-10-27 | 2020-03-30 | Theravance Biopharma R&D Ip Llc | Pyrimidine compound as jak kinase inhibitor |
| WO2019096303A1 (zh) * | 2017-11-20 | 2019-05-23 | 江苏恒瑞医药股份有限公司 | 一种局部给药的药物组合物及其制备方法 |
| JP7268132B2 (ja) | 2018-07-31 | 2023-05-02 | エムシー２・セラピューティクス・リミテッド | 局所用組成物 |
| WO2020136650A1 (en) | 2018-12-25 | 2020-07-02 | Sol-Gel Technologies Ltd. | Treatment of skin disorders with compositions comprising an egfr inhibitor |
| WO2020236950A1 (en) | 2019-05-21 | 2020-11-26 | Dauntless 1, Inc. | Therapeutic microsphere formulations containing charged polymers |
| WO2022027041A1 (en) * | 2020-07-28 | 2022-02-03 | Arcutis Biotherapeutics, Inc. | Topical formulation containing jak inhibitor and laureth-4 |
| EP4237080A1 (en) | 2020-10-29 | 2023-09-06 | Arcutis Biotherapeutics, Inc. | Methods for treating vitiligo lesions having improved efficacy |
| MX2023005763A (es) * | 2020-11-17 | 2023-05-29 | Arcutis Biotherapeutics Inc | Composiciones y metodos para la administracion dermica profunda de farmacos. |
| CN114907353A (zh) * | 2021-02-09 | 2022-08-16 | 明慧医药（杭州）有限公司 | 一种前药化合物及其制备方法和用途 |
| CN114870016B (zh) | 2022-04-21 | 2023-05-26 | 上海博悦生物科技有限公司 | 一种jak抑制剂的微乳泡沫剂及其应用 |
-
2022
- 2022-12-14 CA CA3240662A patent/CA3240662A1/en active Pending
- 2022-12-14 EP EP22847098.5A patent/EP4447930A1/en active Pending
- 2022-12-14 IL IL313482A patent/IL313482A/en unknown
- 2022-12-14 WO PCT/US2022/081535 patent/WO2023114832A1/en not_active Ceased
- 2022-12-14 MX MX2024007437A patent/MX2024007437A/es unknown
- 2022-12-14 JP JP2024536283A patent/JP2024544404A/ja active Pending
- 2022-12-14 US US18/065,772 patent/US12161643B2/en active Active
- 2022-12-14 AU AU2022413551A patent/AU2022413551A1/en active Pending
- 2022-12-14 KR KR1020247023740A patent/KR20240125610A/ko active Pending
-
2024
- 2024-11-27 US US18/962,371 patent/US20250090535A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230181591A1 (en) | 2023-06-15 |
| MX2024007437A (es) | 2024-09-04 |
| AU2022413551A1 (en) | 2024-07-04 |
| CA3240662A1 (en) | 2023-06-22 |
| US20250090535A1 (en) | 2025-03-20 |
| EP4447930A1 (en) | 2024-10-23 |
| WO2023114832A9 (en) | 2023-10-05 |
| WO2023114832A1 (en) | 2023-06-22 |
| KR20240125610A (ko) | 2024-08-19 |
| IL313482A (en) | 2024-08-01 |
| US12161643B2 (en) | 2024-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7402301B2 (ja) | 水混和性の薬学的に許容可能な溶媒の水性ブレンド中のロフルミラストの医薬組成物 | |
| US20230338275A1 (en) | Method and Formulation for Improving Roflumilast Skin Penetration Lag Time | |
| JP7572538B2 (ja) | Ｊａｋ阻害剤およびラウレス－４を含有する局所配合物 | |
| AU2021214399B2 (en) | Topical roflumilast formulation having improved delivery and plasma half-life | |
| WO2025054483A1 (en) | Dosing regimens using topical roflumilast compositions | |
| US12161643B2 (en) | Stable formulations of SHR0302 | |
| CN118660693A (zh) | Shr0302的稳定制剂 | |
| US20250090508A1 (en) | Methods of reducing itch using topical roflumilast compositions | |
| HK40106825A (en) | Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents | |
| EA043055B1 (ru) | Фармацевтические композиции рофлумиласта в водных смесях смешивающихся с водой фармацевтически приемлемых растворителей | |
| HK40041771A (en) | Method and formulation for improving roflumilast skin penetration lag time |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251215 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251215 |